Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affimend, Akston, Altrubio, Astex, C4, Dizal, Hua, Inhibrx, Xeris.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Arcellx, Cognition, Genentech, Glyscend, Inovio, Medicenna, Mind, Myeloid, Rhovac, Sanofi, Scilex, Spine.